Literature DB >> 16130118

Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited.

Eric A Storch1, Nathan Andrew Shapira, Eleni Dimoulas, Gary R Geffken, Tanya K Murphy, Wayne K Goodman.   

Abstract

The factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) has been examined in a number of prior investigations; however, findings have not consistently yielded a stable factor solution. The present study therefore tested the fit of each previously reported factor structure. One hundred thirty-one adults with obsessive-compulsive disorder (OCD) were administered the Y-BOCS; a portion of these participants completed self-report measures of depression and obsessive-compulsive symptoms and were rated on a global impairment index. Consistent with the originally proposed structure, confirmatory factor analyses supported a factor structure comprised of obsession and compulsion factors. Reliability and convergent validity of these factors were generally satisfactory, although divergent validity was not entirely supported. Implications of these findings on scoring the Y-BOCS are discussed. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16130118     DOI: 10.1002/da.20088

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  13 in total

1.  Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition.

Authors:  Gregory S Vogt; Michelle Avendaño-Ortega; Sophie C Schneider; Wayne K Goodman; Eric A Storch
Journal:  J Psychiatr Pract       Date:  2022-07-01       Impact factor: 1.841

2.  Comparing Models of the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) in an Italian Clinical Sample.

Authors:  Caterina Novara; Susanna Pardini; Francesco Cardona; Massimiliano Pastore
Journal:  Front Psychiatry       Date:  2020-08-06       Impact factor: 4.157

Review 3.  Rating scales for anxiety/anxiety disorders.

Authors:  Richard Balon
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

4.  Defining clinical severity in adults with obsessive-compulsive disorder.

Authors:  Eric A Storch; Alessandro S De Nadai; Maria Conceição do Rosário; Roseli G Shavitt; Albina R Torres; Ygor A Ferrão; Euripedes C Miguel; Adam B Lewin; Leonardo F Fontenelle
Journal:  Compr Psychiatry       Date:  2015-08-15       Impact factor: 3.735

5.  The yale-brown obsessive-compulsive scale: factor structure of a large sample.

Authors:  Gideon E Anholt; Patricia van Oppen; Danielle C Cath; Johannes H Smit; Johan A den Boer; Marc J P M Verbraak; Anton J L M van Balkom
Journal:  Front Psychiatry       Date:  2010-07-15       Impact factor: 4.157

Review 6.  D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.

Authors:  Jing Xia; Yanqiu Du; Jiyang Han; Guo Liu; Xumei Wang
Journal:  Drug Des Devel Ther       Date:  2015-04-21       Impact factor: 4.162

Review 7.  Evidence-Based Assessment of Obsessive-Compulsive Disorder.

Authors:  Amy M Rapp; R Lindsay Bergman; John Piacentini; Joseph F McGuire
Journal:  J Cent Nerv Syst Dis       Date:  2016-08-21

8.  Korean self-report version of the yale-brown obsessive-compulsive scale: factor structure, reliability, and validity.

Authors:  Soon-Ho Seol; Jun Soo Kwon; Min-Sup Shin
Journal:  Psychiatry Investig       Date:  2013-01-24       Impact factor: 2.505

9.  Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition.

Authors:  Thanita Hiranyatheb; Ratana Saipanish; Manote Lotrakul; Rungthip Prasertchai; Wanwisa Ketkaew; Sudawan Jullagate; Umaporn Udomsubpayakul; Pichaya Kusalaruk
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-28       Impact factor: 2.570

10.  Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples.

Authors:  Thanita Hiranyatheb; Ratana Saipanish; Manote Lotrakul
Journal:  Neuropsychiatr Dis Treat       Date:  2014-03-13       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.